Product Name | Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab) |
---|---|
CAS | 2101242-53-7 |
Cibisatamab is a T-cell bispecific antibody designed to target carcinoembryonic antigen (CEA) on tumor cells and CD3 on T cells, activating T cells to selectively eliminate CEA-expressing tumors. This humanized antibody has a 2:1 molecular format, enhancing CEA avidity for effective tumor cell targeting. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft